Arto Karjalainen
Orion Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arto Karjalainen.
Cancer Chemotherapy and Pharmacology | 1986
Sinikka Kallio; Lauri Kangas; Guillermo Blanco; Risto Johansson; Arto Karjalainen; Milla Perilä; Ilse Pippo; Hannu Sundquist; Marja Södervall; Reijo Juhani Toivola
SummaryThe basic pharmacological and biochemical properties of a new antiestrogen, Fc-1157a, are described. Fc-1157a is bound specifically and with high affinity to estrogen receptors. The binding is competitive with estradiol. Fc-1157a treatment induces translocation of estrogen receptors from cytoplasm to nucleus. The turnover rate of nuclear estrogen receptors is markedly lower than with estradiol, but is more rapid than after tamoxifen.Fc-1157a is an almost pure antiestrogen in rat uterus, but has intrinsic estrogenic activity in mouse uterus. In animal experiments Fc-1157a has shown antitumor properties, which are described in the companion paper.
European Journal of Pharmaceutical Sciences | 2000
Arto Karjalainen; Arja Kalapudas; Marja Södervall; Olavi Pelkonen; Risto Lammintausta
A series of long-chained diarylalkylimidazoles and diarylalkyltriazoles were synthesized and evaluated for the inhibitory potency for aromatase (estrogen synthetase) activity in human placental microsomes. The relative specificity of inhibition was evaluated by measuring the inhibition of cholesterol side-chain cleavage enzyme (desmolase) in human placental mitochondria and the inhibition of 7-ethoxycoumarin O-deethylase (a typical drug-metabolizing enzyme activity) in rat liver microsomes. The structural requirements including substituent effects for the strongest potency and for the highest specificity were delineated. alpha,omega-Diarylalkyltriazoles and imidazoles were the most interesting molecules, in which the geometric and optical isomerism displayed remarkable selectivity for aromatase inhibition.
Heterocycles | 2005
Jari Yli-Kauhaluoma; Aki Laine; Jari Ratilainen; Arto Karjalainen
A facile method for the preparation of conformationally rigid analogues of the adrenergic α-2 receptor antagonist atipamezole and the adrenergic α-2 receptor agonist medetomidine has been developed. The efficient benzyne [4+2] cycloaddition reaction was used to give the core 7-acetylbenzonorbomadiene structure, which was subsequently elaborated to the corresponding imidazole-based syn and anti isomers by means of the classical Brederecks method.
Cancer Chemotherapy and Pharmacology | 1986
Lauri Kangas; Nieminen Al; Guillermo Blanco; Grönroos M; Kallio S; Arto Karjalainen; Perilä M; Marja Södervall; Reijo Juhani Toivola
Cancer Chemotherapy and Pharmacology | 1986
Kallio S; Lauri Kangas; Guillermo Blanco; Johansson R; Arto Karjalainen; Perilä M; Pippo I; Hannu Sundquist; Marja Södervall; Reijo Juhani Toivola
Archive | 1996
Arto Karjalainen; Paavo Huhtala; Juha-Matti Savola; Siegfried Wurster; Maire Eloranta; Maarit Savola; Raimo Saxlund; Victor Cockcroft; Arja Karjalainen
Archive | 1999
Jarmo Pystynen; Heimo Haikala; Petri Kaheinen; Juha Kaivola; Piero Pollesello; Ismo Ulmanen; Jukka Tenhunen; Carola Tilgmann; Eija Tiainen; Kari Lönnberg; Pentti Nore; Seppo Parhi; Arto Karjalainen; Jouko Levijoki
Archive | 2004
Leena Otsomaa; Tuula Koskelainen; Arto Karjalainen; Sirpa Rasku; Piero Pollesello; Jouko Levijoki
Archive | 2003
David Din Belle; Reija Jokela; Arto Tolvanen; Antti Haapalinna; Arto Karjalainen; Jukka Sallinen; Jari Ratilainen
Archive | 2001
Arto Karjalainen; Paavo Huhtala; Juha-Matti Savola; Siegfried Wurster; Maire Eloranta; Maarit Hillilä; Raimo Saxlund; Victor Cockcroft; Arja Karjalainen